https://www.selleckchem.com/pr....oducts/NVP-AEW541.ht
57 ± 1.58 vs. 4.82 ± 2.06mg/dl, P = 0.017), it returned to baseline levels at 1-month follow-up (3.53 ± 2.72 vs. 4.82 ± 2.06mg/dl, P = 0.401). The patients experienced complete resolution or noticeable reduction of ascites (P 0.001), significant reduction of liver size (16.7 ± 2.2 vs. 13.7 ± 1.7cm, P = 0.018), and significant enlargement of the portal trunk (10.7 ± 2.5 vs. 13.4 ± 2.4mm, P = 0.017) after TIPS compared to the pre-TIPS state. TIPS may offer a potentially useful treatment for the GS-related HSOS. TIPS may offer a po
Like
Comment
Share
